- RTRX is a biotech company led by CEO Martin Shkreli.
- It is an M&A focused company that relies on a high stock price to do deals.
- While the strategy may suceed, there are numerous risks.
Retrophin Inc is a developmental stage biopharmaceutical company engaged in discovery, development and commercialization of novel molecules for the treatment of human genetic disorders. Its RE-021 product is used for the treatment of FSGS.